MYBoard - Expert Advisory Boards | MYELOMA360
Trusted by Top 20 Pharmaceutical Companies
MYBOARD Logo

Transform Your Myeloma Strategy with
Fractional Advisory Boards

All the value of traditional advisory boards, at a fraction of the cost and time



World-Class
KOLs
Past events have included:
Sagar Lonial, Irene Ghobrial,
Ola Landgren, Faith Davies, Maria V Mateos,
Hartmut Goldschmidt, Francesca Gay,
Xavier Leleu and many others.
Valuable
Insights
Executive summary, key insights and
takeaways with a full transcript delivered
within 72 hours.
50-60%
Less Cost
The same high-quality
deliverables as traditional advisory boards
at a fraction of the cost and complexity.

• Access elite myeloma KOLs for strategic, actionable insights that drive results
• Private 2-2.5 hour sessions, scheduled around major conferences like IMS and ASH
• No logistics or contracting hassles, we handle everything from planning to execution
• High-quality deliverables (summary, transcript, insights) included

Upcoming Advisory Board
9/16/2025

MYBoard - September 16th at IMS Conference

+9
12 Global Experts

What is MYBoard?

MYBoard gives you direct access to the world’s top myeloma minds, faster, smarter, and at a fraction of the cost of traditional advisory boards.

Engage in sharp, high-impact discussions with KOLs like Drs. Lonial, Ghobrial, Landgren, and Mateos. Each session is fully customized, expertly moderated, and designed to deliver strategic, actionable insights.

You’ll receive a complete executive summary, transcript, and prioritized recommendations, delivered within 72 hours.

Held alongside major conferences like IMS and ASH, MYBoard sessions run 2-2.5 hours and are fully managed from start to finish. All you do is show up.

Top pharma teams are already using MYBOARD to:

Align Commercial, Medical, and Market Access teams
Pressure-test key messaging to sharpen external communications
Uncover market barriers, competitive intelligence to gain an advantage with collaborators and with customers
Refine clinical development and evidence generation plans
Eliminate venue search, contracting chaos, and endless internal planning cycles

Slots are limited. Ready to see if it's a fit?

Traditional Advisory Boards Are Broken

KOLs are overbooked and hard to schedule
Planning cycles stretch 3–6 months
Costs routinely exceed $100K
Regulatory scrutiny is tightening
Meetings lack focus and drain energy
Too much PowerPoint, not enough insight
Follow-up is slow, unstructured, or absent
Siloed teams create duplicate outreach
ROI is nearly impossible to prove

Top-20 Pharma Companies Choose MYBoard

Proven results that speak for themselves

$61,000+

Saved per advisory vs. traditional formats

3-4 Weeks

Reduced setup time from 4–6 months

100%

Maintained confidentiality and compliance

3 Days

Delivered actionable insights post-session

Elite KOLs

Access to top experts from ASH, IMS, and beyond

The Advantages of Choosing MYBoard

Engage with Leading KOLs

Our advisory boards are co-chaired by renowned myeloma specialists. Participants include leading researchers and clinicians from top institutions worldwide.

300+ Global Experts

Tailored to Your Needs

Each advisory board is driven by the specific needs and objectives of participating organizations, ensuring relevant insights and actionable outcomes.

100% Customized

Cost Efficient

Our structured advisory boards are designed to be both time and cost-efficient, providing high-value insights without the high costs of
traditional events.

50% Cost Savings

Convenient and Flexible

Our structured 2-hour time slots provide an easy way to access high-level expertise without the hassle of organizing separate events.

2-Hour Sessions

Post-Event Deliverables

We provide detailed executive summaries, key takeaways and actionable recommendations within 72 hours of your event.

Comprehensive Reports

All Logistics Included

From expert selection to venue booking, communications, and strategic planning, we manage every aspect of your
advisory event.

Full-Service Support


Enhanced with Value-added Features

1

Precision Thought Leader Recruitment

We secure the best-fit KOLs based on your goals and regional preferences.

2

Rapid Insights Report

Receive a concise executive summary and full report with strategic takeaways and clear, actionable insights, delivered within 72 hours post-session

3

Data Compass Myeloma Conference Reports

Data Compass identifies the signal in thousands of abstracts, highlighting those that challenge standards of care, accelerate innovation, and change practice.

Join us at Major Industry Events

Connect with our experts at the most important myeloma conferences of 2025

Limited advisory board slots available – Reserve yours today!

International Myeloma Society (IMS) Meeting

Sept. 17 - 20, 2025 | Toronto, Canada

Lymphoma, Leukemia & Myeloma Congress

Oct. 14-17, 2025 | New York City

American Society of Hematology

Dec. 6-9, 2025 | Chicago, IL

Frequently Asked Questions

Get answers to common questions about MYBOARD

Is this a shared session with other companies?

No. Each MYBOARD session is private and customized to your company.

Will I know which KOLs are attending?

Yes. You will receive a curated KOL list in advance based on your goals.

Can this be applied to other tumor types or therapeutic areas?

Our current focus is multiple myeloma, but expansion is possible—ask us.

How do you handle compliance?

We manage all documentation, NDAs, and regulatory reporting per global best practices.

What Our Clients Say

Trusted by leading pharmaceutical and biotech companies worldwide

"

"MYBoard transformed our approach to expert engagement. The quality of insights and efficiency of the process exceeded our expectations."

Head of Medical Affairs, Leading Pharma
"

"The cost-effectiveness and quality of MYBoard advisory sessions have made it an essential part of our strategic planning process."

VP Strategy, Biotech Innovation